Streetbeat News

Analyst Ratings

FEMY

GPCR

NKE

Structure Therapeutics announced positive results from Phase 1b clinical study of oral GLP-1 receptor agonist GSBR-1290. HC Wainwright & Co. maintains a buy rating on Femasys and raises the price target to $13. No specific news for NKE.

Portfolio Pulse from ryanfaloona@benzinga.com

September 29, 2023 | 12:42 pm

FROG

JFrog Ltd (NASDAQ:FROG) has announced the appointment of Ed Grabscheid as the new CFO, effective from January 1, 2024. Grabscheid, currently serving as FROG's Vice President of Finance, will replace Jacob Shulman. The company also reaffirmed its Q3 and FY23 outlook, projecting revenues of $343.5 million-$345.5 million and adjusted EPS of $0.26-$0.28 for FY23.

Portfolio Pulse from Lekha Gupta

September 29, 2023 | 12:38 pm

NVOS

White Diamond Research has issued a report suggesting that Novo Integrated Sciences (NVOS) may be involved in a scam with a convicted Ponzi scheme criminal. The report questions NVOS's recent PR about a one billion dollar collateral transfer through Blacksheep Trust, a company chaired by John Paul Baron, who was previously imprisoned for a $3-million Ponzi scheme. White Diamond Research predicts a potential lawsuit from the SEC against NVOS.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 12:33 pm

ZS

Morgan Stanley analyst Hamza Fodderwala maintains an Equal-Weight rating on Zscaler (NASDAQ:ZS) and raises the price target from $145 to $155.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 12:33 pm

MTN

Morgan Stanley analyst Megan Alexander has maintained an Equal-Weight rating on Vail Resorts (NYSE:MTN) and raised the price target from $272 to $276.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 12:32 pm

PODD

Morgan Stanley analyst Patrick Wood has maintained an Equal-Weight rating on Insulet (NASDAQ:PODD) and lowered the price target from $208 to $185.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 12:30 pm

DXCM

Morgan Stanley analyst Patrick Wood has maintained an Equal-Weight rating on DexCom (NASDAQ:DXCM) and lowered the price target from $131 to $98.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 12:28 pm

UPS

Raymond James analyst Patrick Tyler Brown maintains a Strong Buy rating on United Parcel Service (UPS) but lowers the price target from $205 to $200.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 12:24 pm

SBSW

JP Morgan analyst Dominic O'Kane maintains an Overweight rating on Sibanye Stillwater (NYSE:SBSW) but lowers the price target from $13 to $9.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 12:24 pm

HMY

JP Morgan analyst Luke Nelson has maintained a Neutral rating on Harmony Gold Mining Co (NYSE:HMY) and lowered the price target from $5.4 to $3.8.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 12:21 pm